← Leaderboards
Jian-Xing Ma
University Of North Texas Hlth Sci Ctr
$33,274,759
Attributed
$40,295,734
Total exposure
27
Grants
21
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $5.3M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$67,207,663 · 30
By mechanism
P20$29,911,502 · 13
R01$27,208,322 · 11
P30$7,304,030 · 3
R33$1,481,398 · 1
R21$731,832 · 1
UG3$570,579 · 1
Top collaborators
- Gennadiy Moiseyev11 shared
- Dimitrios Karamichos10 shared
- Yusuke Takahashi7 shared
- Qingguo Xu6 shared
- Jiyang Cai3 shared
Most similar at University Of North Texas Hlth Sci Ctr
Same institution · by research overlap
- Dimitrios Karamichos$9,689,481
Others in their field
Top investigators on “Diabetes Mellitus”
- Jeffrey P Krischer · University Of South Florida$608,226,434
- Kathryn Hirst · Caritas St. Elizabeth'S Medical Center$177,347,135
- John M Lachin · George Washington University$155,262,668
- David M Nathan · Massachusetts Institute Of Technology$142,806,023
- Judith S Hochman · New York University School Of Medicine$100,149,457
- Jose A Luchsinger · Columbia University Health Sciences$75,551,718
Research focus
Diabetes MellitusDiabeticRetinaAnimal ModelKnock-OutPathway InteractionsBlindnessCellsPlayInflammationGrantBlood VesselsComplications Of Diabetes MellitusReportingDiabetic RetinopathySignal TransductionFundingGeneticExtravasationPharmaceutical PreparationsBaseKnockout MiceRegulationResearch Personnel
Grant awards (125)
Fenofibrate microemulsion for treating nitrogen mustard induced corneal injury$570,579
UG3 · FY2025 · EY
Sustained release of fenofibrate for the treatment of diabetic retinopathy$538,028
R01 · FY2025 · EY
Dysregulation of PPARα in RPE degeneration$532,135
R01 · FY2025 · EY · contact PI
A new pathogenic mechanism for diabetic retinopathy$474,114
R01 · FY2025 · EY · contact PI
The Impact of Prolactin Induced Protein in Corneal Wound Healing and Fibrosis$465,357
R01 · FY2025 · EY
Metabolic reprogramming of endothelial precursor cells in subretinal fibrosis$448,144
R01 · FY2025 · EY
Studies of retinyl ester hydrolase in the visual cycle$387,501
R01 · FY2025 · EY · contact PI
cGAS-STING signaling in diabetic retinopathy$387,500
R01 · FY2025 · EY · contact PI
A Novel Pathogenic Pathway for Diabetic Keratopathy$378,750
R01 · FY2025 · EY
Sustained release of fenofibrate for the treatment of diabetic retinopathy$23,288
R01 · FY2025 · EY
Sustained release of fenofibrate for the treatment of diabetic retinopathy$538,028
R01 · FY2024 · EY
Dysregulation of PPARα in RPE degeneration$532,135
R01 · FY2024 · EY · contact PI
A new pathogenic mechanism for diabetic retinopathy$474,114
R01 · FY2024 · EY · contact PI
The Impact of Prolactin Induced Protein in Corneal Wound Healing and Fibrosis$465,357
R01 · FY2024 · EY
Metabolic reprogramming of endothelial precursor cells in subretinal fibrosis$448,144
R01 · FY2024 · EY
Studies of retinyl ester hydrolase in the visual cycle$387,501
R01 · FY2024 · EY · contact PI
cGAS-STING signaling in diabetic retinopathy$387,500
R01 · FY2024 · EY · contact PI
A Novel Pathogenic Pathway for Diabetic Keratopathy$378,750
R01 · FY2024 · EY
Dysregulation of PPARα in RPE degeneration$545,885
R01 · FY2023 · EY · contact PI
Sustained release of fenofibrate for the treatment of diabetic retinopathy$538,028
R01 · FY2023 · EY
The Impact of Prolactin Induced Protein in Corneal Wound Healing and Fibrosis$477,357
R01 · FY2023 · EY
Metabolic reprogramming of endothelial precursor cells in subretinal fibrosis$459,394
R01 · FY2023 · EY
A Novel Pathogenic Pathway for Diabetic Keratopathy$390,750
R01 · FY2023 · EY
Studies of retinyl ester hydrolase in the visual cycle$387,501
R01 · FY2023 · EY · contact PI
cGAS-STING signaling in diabetic retinopathy$387,500
R01 · FY2023 · EY · contact PI
Sustained release of fenofibrate for the treatment of diabetic retinopathy$551,841
R01 · FY2022 · EY
cGAS-STING signaling in diabetic retinopathy$387,500
R01 · FY2022 · EY · contact PI
Studies of retinyl ester hydrolase in the visual cycle$375,876
R01 · FY2022 · EY · contact PI
A new pathogenic mechanism for diabetic retinopathy$351,625
R01 · FY2021 · EY · contact PI
Studies of RPE65$334,857
R01 · FY2021 · EY · contact PI
Studies of retinyl ester hydrolase in the visual cycle$316,619
R01 · FY2021 · EY · contact PI
Diabetic Animal Core$296,000
P30 · FY2021 · GM · contact PI
Administrative Core$276,806
P30 · FY2021 · GM · contact PI
Studies of retinyl ester hydrolase in the visual cycle$45,879
R01 · FY2021 · EY · contact PI
Studies of RPE65$16,767
R01 · FY2021 · EY · contact PI
A new pathogenic mechanism for diabetic retinopathy$1
R01 · FY2021 · EY · contact PI
Mentoring Diabetes Research in Oklahoma$1,110,000
P30 · FY2020 · GM · contact PI
Studies of RPE65$362,500
R01 · FY2020 · EY · contact PI
A new pathogenic mechanism for diabetic retinopathy$362,500
R01 · FY2020 · EY · contact PI
Diabetic Animal Core$296,000
P30 · FY2020 · GM · contact PI
Administrative Core$276,806
P30 · FY2020 · GM · contact PI
A Novel Pathogenic Pathway for Diabetic Keratopathy$242,857
R01 · FY2020 · EY · contact PI
A Novel Pathogenic Pathway for Diabetic Keratopathy$47,143
R01 · FY2020 · EY · contact PI
Mentoring Diabetes Research in Oklahoma$1,110,000
P30 · FY2019 · GM · contact PI
Studies of RPE65$362,500
R01 · FY2019 · EY · contact PI
A new pathogenic mechanism for diabetic retinopathy$362,500
R01 · FY2019 · EY · contact PI
The role of the Wnt signaling pathway in choroidal neovascularization$333,000
R01 · FY2019 · EY · contact PI
Diabetic Animal Core$296,000
P30 · FY2019 · GM · contact PI
A Novel Pathogenic Pathway for Diabetic Keratopathy$290,000
R01 · FY2019 · EY
Administrative Core$276,806
P30 · FY2019 · GM · contact PI
Mentoring Diabetes Research in Oklahoma$1,110,000
P30 · FY2018 · GM · contact PI
A new pathogenic mechanism for diabetic retinopathy$362,500
R01 · FY2018 · EY · contact PI
Studies of RPE65$362,500
R01 · FY2018 · EY · contact PI
The role of the Wnt signaling pathway in choroidal neovascularization$333,000
R01 · FY2018 · EY · contact PI
Diabetic Animal Core$296,000
P30 · FY2018 · GM · contact PI
A Novel Pathogenic Pathway for Diabetic Keratopathy$290,000
R01 · FY2018 · EY
Administrative Core$276,806
P30 · FY2018 · GM · contact PI
Mentoring Diabetes Research in Oklahoma$1,110,000
P30 · FY2017 · GM · contact PI
A new pathogenic mechanism for diabetic retinopathy$370,000
R01 · FY2017 · EY · contact PI
The role of the Wnt signaling pathway in choroidal neovascularization$333,000
R01 · FY2017 · EY · contact PI
Diabetic Animal Core$296,000
P30 · FY2017 · GM · contact PI
Administrative Core$276,806
P30 · FY2017 · GM · contact PI
Mentoring Diabetes Research in Oklahoma$2,137,761
P20 · FY2016 · GM · contact PI
Administrative/Mentoring Core$657,905
P20 · FY2016 · GM · contact PI
A new pathogenic mechanism for diabetic retinopathy$370,000
R01 · FY2016 · EY · contact PI
The role of the Wnt signaling pathway in choroidal neovascularization$333,000
R01 · FY2016 · EY · contact PI
Mentoring Diabetes Research in Oklahoma$2,160,123
P20 · FY2015 · GM · contact PI
Administrative/Mentoring Core$656,462
P20 · FY2015 · GM · contact PI
Studies of RPE65$370,000
R01 · FY2015 · EY · contact PI
A new pathogenic mechanism for diabetic retinopathy$362,600
R01 · FY2015 · EY · contact PI
The role of the Wnt signaling pathway in choroidal neovascularization$333,000
R01 · FY2015 · EY · contact PI
Mentoring Diabetes Research in Oklahoma$2,164,094
P20 · FY2014 · GM · contact PI
Administrative/Mentoring Core$656,483
P20 · FY2014 · GM · contact PI
A new pathogenic mechanism for diabetic retinopathy$362,600
R01 · FY2014 · EY · contact PI
Mentoring Diabetes Research in Oklahoma$2,109,366
P20 · FY2013 · GM · contact PI
Administrative/Mentoring Core$633,619
P20 · FY2013 · GM · contact PI
The role of the wnt signaling pathway in choroidal neovascularization$448,496
R01 · FY2013 · EY · contact PI
A new pathogenic mechanism for diabetic retinopathy$370,000
R01 · FY2013 · EY · contact PI
Studies of RPE65$337,440
R01 · FY2013 · EY · contact PI
Mentoring Diabetes Research in Oklahoma$2,245,038
P20 · FY2012 · GM · contact PI
Administrative/Mentoring Core$667,295
P20 · FY2012 · GM · contact PI
The role of the wnt signaling pathway in choroidal neovascularization$448,496
R01 · FY2012 · EY · contact PI
Studies of RPE65$355,200
R01 · FY2012 · EY · contact PI
The role of the wnt signaling pathway in choroidal neovascularization$43,007
R01 · FY2012 · EY · contact PI
Mentoring Diabetes Research in Oklahoma$2,108,888
P20 · FY2011 · RR · contact PI
OKHSC COBRE: ADMINISTRATIVE AND MENTORING CORE$503,876
P20 · FY2011 · RR · contact PI
The role of the wnt signaling pathway in choroidal neovascularization$370,000
R01 · FY2011 · EY · contact PI
Studies of RPE65$355,200
R01 · FY2011 · EY · contact PI
A new pathogenic mechanism for diabetic retinopathy$351,600
R01 · FY2011 · EY · contact PI
OKHSC COBRE: DIABETIC ANIMAL CORE$311,588
P20 · FY2011 · RR · contact PI
Mentoring Diabetes Research in Oklahoma$2,130,190
P20 · FY2010 · RR · contact PI
OKHSC COBRE: ADMINISTRATIVE AND MENTORING CORE$522,129
P20 · FY2010 · RR · contact PI
Studies of RPE65$370,000
R01 · FY2010 · EY · contact PI
A new pathogenic mechanism for diabetic retinopathy$369,518
R01 · FY2010 · EY · contact PI
The wnt signaling pathway in choroidal neovascularization$366,250
R01 · FY2010 · EY · contact PI
OKHSC COBRE: DIABETIC ANIMAL CORE$331,074
P20 · FY2010 · RR · contact PI
Mentoring Diabetes Research in Oklahoma$2,115,886
P20 · FY2009 · RR · contact PI
Mentoring Diabetes Research in Oklahoma$997,203
P20 · FY2009 · RR · contact PI
OKHSC COBRE: ADMINISTRATIVE AND MENTORING CORE$504,279
P20 · FY2009 · RR · contact PI
The wnt signaling pathway in choroidal neovascularization$366,250
R01 · FY2009 · EY · contact PI
A new pathogenic mechanism for diabetic retinopathy$366,250
R01 · FY2009 · EY · contact PI
Studies of RPE65$355,629
R01 · FY2009 · EY · contact PI
OKHSC COBRE: DIABETIC ANIMAL CORE$330,501
P20 · FY2009 · RR · contact PI
A new pathogenic mechanism for diabetic retinopathy$293,100
R01 · FY2009 · EY · contact PI
Mentoring Diabetes Research in Oklahoma$2,120,116
P20 · FY2008 · RR · contact PI
OKHSC COBRE: ADMINISTRATIVE AND MENTORING CORE$509,618
P20 · FY2008 · RR · contact PI
Studies of RPE65$348,516
R01 · FY2008 · EY · contact PI
OKHSC COBRE: DIABETIC ANIMAL CORE$283,995
P20 · FY2008 · RR · contact PI
Mentoring Diabetes Research in Oklahoma$6,392
P20 · FY2008 · RR · contact PI
Mentoring Diabetes Research in Oklahoma$2,176,872
P20 · FY2007 · RR · contact PI
OKHSC COBRE: ADMINISTRATIVE AND MENTORING CORE$565,987
P20 · FY2007 · RR · contact PI
A New Therapy for Diabetic Macular Edema$504,203
R33 · FY2007 · EY · contact PI
Studies of RPE65$355,629
R01 · FY2007 · EY · contact PI
OKHSC COBRE: DIABETIC ANIMAL CORE$304,762
P20 · FY2007 · RR · contact PI
A New Therapy for Diabetic Macular Edema$453,145
R33 · FY2006 · EY · contact PI
Studies of RPE65$366,250
R01 · FY2006 · EY · contact PI
A New Therapy for Diabetic Macular Edema$524,050
R33 · FY2005 · EY
A New Therapy for Diabetic Macular Edema$365,916
R21 · FY2004 · EY
Studies of RPE65$219,750
R01 · FY2004 · EY
A New Therapy for Diabetic Macular Edema$365,916
R21 · FY2003 · EY
Studies of RPE65$219,750
R01 · FY2003 · EY
Studies of RPE65$214,500
R01 · FY2002 · EY
Studies of RPE65$214,500
R01 · FY2001 · EY
RETINAL CAPILLARIES IN DIABETIC RETINOPATHY$201,120
R01 · FY2000 · EY
STUDIES OF RPE65$142,945
R01 · FY2000 · EY